DCPH - Deciphera Pharmaceuticals, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5784.79M
Enterprise Value 3538.13M
Trailing P/E N/A
Forward P/E 1-4.76
PEG Ratio (5 yr expected) 1-0.23
Price/Sales (ttm)N/A
Price/Book (mrq)3.27
Enterprise Value/Revenue 3N/A
Enterprise Value/EBITDA 6-4.11

Trading Information

Stock Price History

Beta (3Y Monthly) N/A
52-Week Change 3-44.81%
S&P500 52-Week Change 36.69%
52 Week High 341.00
52 Week Low 318.55
50-Day Moving Average 322.90
200-Day Moving Average 324.54

Share Statistics

Avg Vol (3 month) 3224.73k
Avg Vol (10 day) 3252.64k
Shares Outstanding 538.19M
Float 13.72M
% Held by Insiders 144.03%
% Held by Institutions 158.37%
Shares Short (Jun 28, 2019) 43.53M
Short Ratio (Jun 28, 2019) 411.96
Short % of Float (Jun 28, 2019) 421.51%
Short % of Shares Outstanding (Jun 28, 2019) 49.25%
Shares Short (prior month May 31, 2019) 43.6M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Mar 31, 2019


Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-36.29%
Return on Equity (ttm)-62.19%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -130.81M
Net Income Avi to Common (ttm)-125.81M
Diluted EPS (ttm)-3.42
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)262.34M
Total Cash Per Share (mrq)6.87
Total Debt (mrq)1.94M
Total Debt/Equity (mrq)0.81
Current Ratio (mrq)9.55
Book Value Per Share (mrq)6.28

Cash Flow Statement

Operating Cash Flow (ttm)-103.09M
Levered Free Cash Flow (ttm)-60.5M